PEG Derivatives Apply in Drug Delivery and Diagnostics

Products

MSDS

Drug Delivery

Drug delivery describes the tactic and approach to delivering medicine or prescription drugs and alternative xenobiotics to their website of action among an organism, with the goal of achieving a therapeutic outcome. problems with pharmacodynamics and pharmacology square measure necessary concerns for drug delivery.

The PEGylated drug delivery system is a cutting-edge application of PEG derivatives in the pharmaceutical field. The PEGylation technology can also be used in delivery systems for drugs such as siRNA, mRNA, pDNA, etc. Among many drug delivery systems, PEGylated LNP（Lipid Nanoparticle）drug delivery system is widely used for the mRNA and siRNA drug delivery. For example, PEGylated LNPs are used in Pfizer/BioNTech and Moderna's COVID-19 mRNA vaccines.

Biopharma PEG provides PEG linkers from lab to GMP commercial scale for your drug delivery. Contact us at sales@biochempeg.com if you are interested in our PEG products.

References:
1. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99(Pt A):28-51. doi:10.1016/j.addr.2015.09.012

Catalog No.	Name	Structure	M.W.	Purity	Buy
MF001002	mPEG-OH			≥95%

MF001050	mPEG-NH2.HCl			≥95%

MF001017	mPEG-COOH			≥95%

MF001003	mPEG-SH			≥95%

MF001121	mPEG-AA			≥95%

MF001096	mPEG-DSPE			≥95%

MF001317	mPEG-DMG			≥95%

MF001318	mPEG-N,N-Ditetradecylacetamide			≥95%

MF001098	mPEG-DPPE			≥95%

MF001004	mPEG-CHO			≥95%

MF001022	mPEG-Mal			≥95%

MF001170	mPEG-CH2CH2CH2-NH2			≥95%

MF001163	mPEG-PLGA(75:25)(5K)			≥95%

MF001023	mPEG-SC			≥95%

LP096005	DSPE-PEG-NH2			≥95%

HE005017	NH2-PEG-COOH			≥95%

HE017050	COOH-PEG-NH2.HCl			≥95%

LP096072	DSPE-PEG-Galactose			≥95%

LP096002	DSPE-PEG-OH			≥95%

LP097022	DMPE-PEG-Mal			≥95%

LP100022	DOPE-PEG-Mal			≥95%

HE022002	Mal-PEG-OH			≥95%

HE022123	Mal-NH-PEG-NH2.TFA			≥95%

HE022024	Mal-PEG-SCM			≥95%